Dolev Rafaeli

Epitomee Medical, having lost 61% of its value over the past year, has appointed Dolev Rafaeli as CEO amidst a crisis. Rafaeli previously led a public company that collapsed, raising questions among investors about whether this is a strategic turnaround or a prelude to a sale.